- Home
- AUUD vs GLMD Comparison
AUUD vs GLMD Comparison
Compare AUUD & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- GLMD
- Stock Information
- Founded
- AUUD 2012
- GLMD 2000
- Country
- AUUD United States
- GLMD Israel
- Employees
- AUUD N/A
- GLMD N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- AUUD Technology
- GLMD Health Care
- Exchange
- AUUD Nasdaq
- GLMD Nasdaq
- Market Cap
- AUUD 2.9M
- GLMD 3.0M
- IPO Year
- AUUD 2021
- GLMD 2014
- Fundamental
- Price
- AUUD $6.12
- GLMD $1.81
- Analyst Decision
- AUUD
- GLMD Hold
- Analyst Count
- AUUD 0
- GLMD 1
- Target Price
- AUUD N/A
- GLMD N/A
- AVG Volume (30 Days)
- AUUD 66.5K
- GLMD 364.3K
- Earning Date
- AUUD 08-06-2025
- GLMD 05-22-2025
- Dividend Yield
- AUUD N/A
- GLMD N/A
- EPS Growth
- AUUD N/A
- GLMD N/A
- EPS
- AUUD N/A
- GLMD N/A
- Revenue
- AUUD N/A
- GLMD N/A
- Revenue This Year
- AUUD N/A
- GLMD N/A
- Revenue Next Year
- AUUD N/A
- GLMD N/A
- P/E Ratio
- AUUD N/A
- GLMD N/A
- Revenue Growth
- AUUD N/A
- GLMD N/A
- 52 Week Low
- AUUD $2.88
- GLMD $1.15
- 52 Week High
- AUUD $31.62
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- AUUD 49.64
- GLMD 61.13
- Support Level
- AUUD $4.11
- GLMD $1.63
- Resistance Level
- AUUD $4.54
- GLMD $1.94
- Average True Range (ATR)
- AUUD 0.41
- GLMD 0.12
- MACD
- AUUD -0.08
- GLMD 0.01
- Stochastic Oscillator
- AUUD 30.77
- GLMD 69.77
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.